galantamine and physostigmine

galantamine has been researched along with physostigmine in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (24.24)	18.7374
1990's	11 (16.67)	18.2507
2000's	21 (31.82)	29.6817
2010's	13 (19.70)	24.3611
2020's	5 (7.58)	2.80

Authors

Authors	Studies
Bigg, DC; Briley, M; Calmel, F; Carilla, E; Vidaluc, JL	1
Bigg, D; Briley, M; Calmel, F; Carilla, E; Chopin, P; Stenger, A; Vidaluc, JL	1
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X	1
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M	1
Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS	1
Decker, M; Lehmann, J; Rommelspacher, H; Schott, Y	1
Arnold, N; Brandt, W; Geissler, T; Kehlen, A; Porzel, A; Schlenzig, D; Wessjohann, L	1
Bellman, K; Knegtel, RM; Settimo, L	1
Ansari, FL; Hall, CD; Jabeen, F; Katritzky, AR; Oliferenko, AA; Oliferenko, PV; Pillai, GG	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Awang, K; Khaw, KY; Liew, SY; Litaudon, M; Murugaiyah, V; Wan Othman, WNN	1
Darekar, MN; Gurjar, AS; Ooi, L; Yeong, KY	1
Ji, J; Peng, Y; Rakesh, KP; Wang, S; Xu, M; Zhu, L	1
Al Mamun, A; Cahlíková, L; Hulcová, D; Kobrlová, T; Kohelová, E; Korábečný, J; Kučera, T; Kuneš, J; Maříková, J; Nováková, L; Peřinová, R; Ritomská, A	1
Curtis, MA; Lin, SX; Sperry, J	1
Cahlíková, L; Carmen Catapano, M; Hulcová, D; Janoušek, J; Jenčo, J; Kohelová, E; Korábečný, J; Kučera, T; Kuneš, J; Maafi, N; Maříková, J; Mecava, M; Nováková, L; Pidaný, F; Prchal, L; Schmidt, M; Shammari, LA; Špulák, M	1
Andricopulo, AD; Cenci, AR; de Oliveira, AS; Ferreira, LLG; Machado, V; Nunes, RJ; Sandjo, LP; Sens, L; Teixeira, KF; Tizziani, T; Yunes, RA	1
Aleksandriĭskaia, IE; Brestkina, LM; Sofronov, GA; Tonkopiĭ, VD	1
Cozanitis, DA	1
Barz, H; Bickel, U; Cervos-Navarro, J; Fischer, JP; Gusztony, G; Kaden, B; Kewitz, H; Thomsen, T	1
Dubovitskaia, SI; Khromova, ON; Prozorovskiĭ, VB; Vladeeva, NV	1
Schmidt, J; Wolf, H	1
Andreas, K; Lehmann, K; Walther, H	1
Kumbier, E; Liebmann, H; Matthies, H	1
Gladysheva, NI; Khromova, ON; Prozorovskiĭ, VB	1
Prozorovskiĭ, VB	1
Gumulka, W; Kostowski, W	1
Chanley, JD; Durant, RC; Friess, SL; Mezzetti, T	1
Il'iuchenok, RIu; Nesterenko, LN	1
Kagei, K; Koshiro, A; Shirai, H; Uyeo, S; Yashiro, T	1
Cozanitis, DA; Friedmann, T; Fürst, S	1
Ducardus, R; Dworacek, B; Dzoljic, MR; Rupreht, J; Schmitz, PI	1
Krivoĭ, II; Kuleshov, VI; Matiushkin, DP; Sanotskiĭ, VI; Shabunova, IA	1
Abdel Ghani, EM; Cooper, JC; Gutbrod, O; Hermsen, B; Lobron, C; Reinhardt, S; Schrattenholz, A; Soskiç, V; Storch, A; Weber, KH	1
Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G	1
Feng, J; Liu, JS; Tang, XC; Xu, H; Zhou, TX	1
Albuquerque, EX; Alkondon, M; Lindstrom, J; Maelicke, A; Peng, X; Pereira, EF; Reinhardt, S; Whiting, P	1
Johansson, M; Nordberg, A	1
Albuquerque, EX; Maelicke, A; Pereira, EF; Reinhardt-Maelicke, S; Schrattenholz, A	1
Camacho, F; Smith, CP; Vargas, HM; Winslow, JT	1
Mielke, R	1
Robert, P	1
Houghton, PJ; Howes, MJ; Perry, NS	1
Harmon, HJ; Legako, JA; White, BJ	1
Butler, R; Prabhakaran, P; Warner, J	1
PODLESNAIA, AI	1
Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H	1
Arya, P; Butler, R; Warner, J	2
Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R	1
Bottlaender, M; Coulon, C; Dollé, F; Ottaviani, M; Syrota, A; Valette, H	1
Bertchume, A; Colvin, J; Csernansky, JG; Dong, H; Martin, M; Shah, R	1
Castro, A; Martinez, A	1
Butler, R; Warner, J; Wuntakal, B	1
Collins, D; Easwaramoorthy, B; Leslie, FM; Mukherjee, J; Pichika, R; Potkin, SG	1
Kircher, T; Leucht, S; Thienel, R; Voss, B	1
Bajda, M; Malawska, B; Musiał, A	1
Ehret, A; Feuerstein, TJ; Förster, S; Jackisch, R; Kammerer, M; Rothmaier, AK; Zentner, J	1
Ilavazhagan, G; Maiti, P; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P	2
Auber, A; Chiamulera, C; Giarola, A	1
Ilavazhagan, G; Maiti, P; Muthuraju, S; Pati, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P	1
Cohen, JB; Hamouda, AK; Kimm, T	1
Cesario, A; Del Bufalo, A; Fini, M; Frustaci, A; Russo, P	1
Barnhart, TE; Christian, BT; Farhoud, M; Higgins, AT; Hillmer, AT; Lao, PJ; Mukherjee, J; Wooten, DW	1
Fitzgerald, PJ; Ghimire, A; Hale, PJ; Watson, BO	1

Reviews

14 review(s) available for galantamine and physostigmine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships. European journal of medicinal chemistry, 2019, Oct-15, Volume: 180 Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles	2019
Pyridine alkaloids with activity in the central nervous system. Bioorganic & medicinal chemistry, 2020, 12-15, Volume: 28, Issue:24 Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic	2020
Pharmacokinetic studies of cholinesterase inhibitors. Acta neurologica Scandinavica. Supplementum, 1993, Volume: 149 Topics: Adult; Aged; Alzheimer Disease; Female; Galantamine; Humans; Male; Middle Aged; Physostigmine; Tacrine	1993
Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine. Current medical research and opinion, 2002, Volume: 18, Issue:3 Topics: Acetylcholine; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Disease Progression; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Phenylcarbamates; Physostigmine; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome	2002
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytotherapy research : PTR, 2003, Volume: 17, Issue:1 Topics: Alkaloids; Alzheimer Disease; Estrogens, Non-Steroidal; Galantamine; Humans; Isoflavones; Physostigmine; Phytoestrogens; Phytotherapy; Plant Extracts; Plant Preparations; Plants, Medicinal; Sesquiterpenes	2003
Dementia. Clinical evidence, 2003, Issue:9 Topics: Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Carbamates; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phosphatidylcholines; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine; Vitamin E	2003
Dementia. Clinical evidence, 2004, Issue:11 Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E	2004
Dementia. Clinical evidence, 2004, Issue:12 Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine	2004
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:1 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Galantamine; Humans; Physostigmine; Protein Conformation	2006
Dementia. Clinical evidence, 2005, Issue:14 Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine	2005
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview]. Der Nervenarzt, 2008, Volume: 79, Issue:1 Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2008
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Current medicinal chemistry, 2007, Volume: 14, Issue:25 Topics: Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Indole Alkaloids; Isoquinolines; Phenylcarbamates; Physostigmine; Piperidines; Propidium; Rivastigmine; Steroids; Tacrine	2007
Multitarget drugs of plants origin acting on Alzheimer's disease. Current medicinal chemistry, 2013, Volume: 20, Issue:13 Topics: Alkaloids; Alzheimer Disease; Animals; Biological Products; Cholinesterase Inhibitors; Crocus; Drug Discovery; Galantamine; Galanthus; Ginkgo biloba; Humans; Huperzia; Neuroprotective Agents; Physostigmine; Plant Extracts; Plants; Salvia; Sesquiterpenes	2013

Trials

1 trial(s) available for galantamine and physostigmine

Article	Year
Cholinergic neurotransmission, REM sleep and depression. Journal of psychosomatic research, 1994, Volume: 38 Suppl 1 Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine	1994

Article

Year

Cholinergic neurotransmission, REM sleep and depression.

Journal of psychosomatic research, 1994, Volume: 38 Suppl 1

Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine

1994

Other Studies

51 other study(ies) available for galantamine and physostigmine

Article	Year
Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluation. Journal of medicinal chemistry, 1995, Jul-21, Volume: 38, Issue:15 Topics: Animals; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Molecular Conformation; Rats; Structure-Activity Relationship; Thiourea	1995
Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity. Journal of medicinal chemistry, 1994, Mar-04, Volume: 37, Issue:5 Topics: Acetylcholinesterase; Amnesia; Animals; Avoidance Learning; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Hydrogen Bonding; Mice; Molecular Conformation; Molecular Structure; Piperidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea	1994
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines. Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17 Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship	2002
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. Journal of medicinal chemistry, 2005, Feb-24, Volume: 48, Issue:4 Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship	2005
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. Journal of medicinal chemistry, 2006, Apr-06, Volume: 49, Issue:7 Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo	2006
6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors. Bioorganic & medicinal chemistry letters, 2006, Nov-15, Volume: 16, Issue:22 Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Galantamine; Humans; Inhibitory Concentration 50; Phenylcarbamates; Physostigmine; Rivastigmine; Serotonin	2006
Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Acetylcholinesterase; Agaricales; Animals; Cattle; Cholinesterase Inhibitors; Erythrocytes; Fruiting Bodies, Fungal; Heterocyclic Compounds, 4 or More Rings; Molecular Structure; Stereoisomerism; Structure-Activity Relationship	2010
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis. European journal of medicinal chemistry, 2014, Jun-10, Volume: 80 Topics: alpha-Glucosidases; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Glycoside Hydrolase Inhibitors; Inhibitory Concentration 50; Quantitative Structure-Activity Relationship	2014
Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae). Bioorganic & medicinal chemistry, 2016, 09-15, Volume: 24, Issue:18 Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cryptocarya; Humans; Inhibitory Concentration 50; Isoquinolines; Kinetics; Molecular Docking Simulation; Plant Extracts; Spectrum Analysis	2016
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease. Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophorus; Female; Horses; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship	2018
Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase. Journal of natural products, 2020, 05-22, Volume: 83, Issue:5 Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Esters; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Substrate Specificity	2020
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study. Bioorganic & medicinal chemistry letters, 2021, 11-01, Volume: 51 Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoquinolines; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship	2021
Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. RSC medicinal chemistry, 2022, Dec-14, Volume: 13, Issue:12 Topics:	2022
[Mechanism of the effect of diazepam on acetylcholine concentration in mouse brain]. Biulleten' eksperimental'noi biologii i meditsiny, 1978, Volume: 86, Issue:7 Topics: Acetylcholine; Acetylcholinesterase; Animals; Brain; Brain Chemistry; Cholinesterase Inhibitors; Diazepam; Dose-Response Relationship, Drug; Galantamine; Lethal Dose 50; Male; Mice; Nitrobenzenes; Organophosphorus Compounds; Paraoxon; Physostigmine	1978
[Galanthamine hydrobromide : a substitute for eserine sulphate (physostigmine) in the treatment of the cerebral effects of anti-cholinergic substances]. La Nouvelle presse medicale, 1978, Volume: 7, Issue:45 Topics: Animals; Brain Diseases; Galantamine; Humans; Parasympatholytics; Physostigmine	1978
Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine. European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1991, Volume: 29, Issue:8 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Erythrocytes; Female; Galantamine; Hippocampus; Humans; Male; Mice; Middle Aged; Physostigmine; Tacrine	1991
[The antimyorelaxant effect of cholinopotentiating drugs]. Biulleten' eksperimental'noi biologii i meditsiny, 1970, Volume: 69, Issue:6 Topics: Ambenonium Chloride; Animals; Anura; Cholinesterase Inhibitors; Colorimetry; Galantamine; Male; Miotics; Neostigmine; Neuromuscular Nondepolarizing Agents; Organophosphonates; Phosphates; Physostigmine; Rats; Tubocurarine	1970
[Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation]. Acta biologica et medica Germanica, 1972, Volume: 29, Issue:4 Topics: Animals; Atropine; Brain; Cholinesterase Inhibitors; Dental Pulp; Electric Stimulation; Evoked Potentials; Female; Galantamine; Isoflurophate; Male; Paraoxon; Physostigmine; Rabbits	1972
[Dose-action relationship in cholinergically induced theta rhythm in the rat hippocampus]. Acta biologica et medica Germanica, 1971, Volume: 27, Issue:4 Topics: Animals; Bromides; Electrodes, Implanted; Electroencephalography; Evoked Potentials; Galantamine; Hippocampus; Nicotinic Acids; Parasympathomimetics; Physostigmine; Rats; Rats, Inbred Strains; Salicylates; Tremorine	1971
[Effect of phenelzine on the toxicity of cholinergic drugs modified by reserpine]. Acta biologica et medica Germanica, 1971, Volume: 26, Issue:3 Topics: Animals; Cholinesterase Inhibitors; Drug Interactions; Female; Galantamine; Isoflurophate; Lethal Dose 50; Male; Mice; Monoamine Oxidase Inhibitors; Neostigmine; Paraoxon; Parasympathomimetics; Phenelzine; Physostigmine; Reserpine; Toxicology	1971
[Reactivity of isolated rat intestine to choline potentiating compounds]. Farmakologiia i toksikologiia, 1971, Volume: 34, Issue:1 Topics: Acetylcholine; Ambenonium Chloride; Animals; Cholinesterase Inhibitors; Depression, Chemical; Galantamine; Ileum; In Vitro Techniques; Male; Miotics; Muscle Contraction; Muscle, Smooth; Neostigmine; Nicotine; Nicotinic Acids; Organophosphonates; Parasympathomimetics; Phosphates; Physostigmine; Rats; Stimulation, Chemical	1971
[Alteration of the primary response of the somatosensory area of the cortex on exposure to choline potentiating substances]. Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova, 1967, Volume: 53, Issue:8 Topics: Animals; Cats; Cerebral Cortex; Cholinesterase Inhibitors; Electrophysiology; Epinephrine; Evoked Potentials; Galantamine; Neostigmine; Neurons; Parasympathetic Nervous System; Parasympatholytics; Physostigmine; Radial Nerve	1967
Note on the ganglionic and central actions of galantamine. International journal of neuropharmacology, 1968, Volume: 7, Issue:1 Topics: Acetylcholine; Animals; Atropine; Benactyzine; Cats; Cerebral Cortex; Electroencephalography; Evoked Potentials; Galantamine; Ganglia, Autonomic; Hexamethonium Compounds; Hippocampus; Phenobarbital; Physostigmine; Stimulation, Chemical; Tubocurarine	1968
Some structural requirements underlying holothurin A interactions with synaptic chemoreceptors. Biochemical pharmacology, 1965, Volume: 14, Issue:8 Topics: Animals; Chemical Phenomena; Chemistry, Physical; Diaphragm; Galantamine; In Vitro Techniques; Neostigmine; Neurochemistry; Neuromuscular Junction; Phrenic Nerve; Physostigmine; Rats; Sensory Receptor Cells; Toxins, Biological	1965
[Acetylcholinesterase and the bioelectrical activity of the brain under the action of eserine and galanthamine in animals with premesencephalic section of the brain]. Biulleten' eksperimental'noi biologii i meditsiny, 1965, Volume: 60, Issue:10 Topics: Acetylcholinesterase; Animals; Brain; Cats; Electroencephalography; Galantamine; Mesencephalon; Physostigmine; Reticular Formation	1965
Galanthamine chemistry. VII. Synthesis of analogues of galanthamine. Chemical & pharmaceutical bulletin, 1966, Volume: 14, Issue:9 Topics: Animals; Chemistry, Organic; Cholinesterase Inhibitors; Galantamine; Neostigmine; Organic Chemistry Phenomena; Physostigmine	1966
Study of the analgesic effects of galanthamine, a cholinesterase inhibitor. Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 266, Issue:2 Topics: Analgesics; Anesthesia; Animals; Barbiturates; Cats; Drug Synergism; Female; Galantamine; Guinea Pigs; In Vitro Techniques; Male; Mice; Morphine; Muscle Contraction; Muscle, Smooth; Physostigmine; Rats; Reaction Time	1983
The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice. Anesthesiology, 1983, Volume: 58, Issue:6 Topics: Animals; Brain; Endorphins; Galantamine; Humans; Male; Mice; Naloxone; Nitrous Oxide; Parasympathetic Nervous System; Physostigmine; Seizures; Substance Withdrawal Syndrome	1983
[Effect of cholinesterase inhibitors on the electrical excitability of the membrane of frog muscle fiber]. Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova, 1982, Volume: 68, Issue:9 Topics: Action Potentials; Animals; Anura; Armin; Cholinesterase Inhibitors; Drug Interactions; Electric Stimulation; Galantamine; In Vitro Techniques; Neuromuscular Junction; Physostigmine; Synaptic Membranes	1982
Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. European journal of pharmacology, 1995, Aug-15, Volume: 290, Issue:3 Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Codeine; Galantamine; In Situ Hybridization; Ion Channels; Ligands; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; PC12 Cells; Physostigmine; Rats; Rats, Wistar; Receptors, Nicotinic; Structure-Activity Relationship	1995
Effect of cholinesterase inhibition in vitro by huperzine analogs. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1994, Volume: 15, Issue:2 Topics: Acetylcholinesterase; Alkaloids; Animals; Cholinesterase Inhibitors; Erythrocyte Membrane; Galantamine; Physostigmine; Rats; Sesquiterpenes; Structure-Activity Relationship	1994
Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:2 Topics: Animals; Antibodies, Monoclonal; Bacterial Toxins; Binding Sites; Cells, Cultured; Chickens; Cyanobacteria Toxins; Dexamethasone; Dose-Response Relationship, Drug; Fibroblasts; Galantamine; Kinetics; Marine Toxins; Membrane Potentials; Microcystins; Molecular Probes; Neurons; Nicotine; Physostigmine; Receptors, Nicotinic; Recombinant Proteins; Tropanes	1994
Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3 Topics: Amino Acid Sequence; Animals; Antibodies; Binding Sites; Cells, Cultured; Evoked Potentials; Female; Fibroblasts; Galantamine; Hippocampus; Immunohistochemistry; Kinetics; Membranes; Molecular Sequence Data; Neurons; Physostigmine; Pregnancy; Quaternary Ammonium Compounds; Rats; Receptors, Nicotinic	1993
Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat. Psychopharmacology, 1996, Volume: 124, Issue:4 Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Benzazepines; Cholinesterase Inhibitors; Drug Synergism; Galantamine; Idazoxan; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine; Yohimbine	1996
[Neuroprotective therapy of Alzheimer's disease?]. Deutsche medizinische Wochenschrift (1946), 1996, Nov-29, Volume: 121, Issue:48 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Neuroprotective Agents; Physostigmine; Piracetam; Tacrine	1996
Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase. Biosensors & bioelectronics, 2003, Volume: 18, Issue:5-6 Topics: Acetylcholinesterase; Binding, Competitive; Biosensing Techniques; Cholinesterase Inhibitors; Diazinon; Enzymes, Immobilized; Equipment Design; Equipment Failure Analysis; Equipment Reuse; Galantamine; Indicators and Reagents; Octoxynol; Physostigmine; Porphyrins; Quality Control; Reproducibility of Results; Scopolamine; Sensitivity and Specificity; Spectrum Analysis; Tetracaine	2003
[PARAMYON-INDUCED CONTRACTURE OF THE DORSAL MUSCLE OF A LEECH UNDER THE EFFECT OF ANTICHOLINESTERASE AGENTS]. Biulleten' eksperimental'noi biologii i meditsiny, 1963, Volume: 55 Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Contracture; Galantamine; Leeches; Leeching; Muscle Relaxants, Central; Neostigmine; Pharmacology; Physostigmine; Research	1963
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. European journal of pharmacology, 2004, Oct-25, Volume: 503, Issue:1-3 Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens	2004
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism. European journal of pharmacology, 2005, Feb-21, Volume: 509, Issue:2-3 Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis	2005
Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys. Synapse (New York, N.Y.), 2005, Jun-15, Volume: 56, Issue:4 Topics: Analysis of Variance; Animals; Azetidines; Binding, Competitive; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Galantamine; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Papio papio; Physostigmine; Positron-Emission Tomography; Reproducibility of Results; Time Factors; Tissue Distribution	2005
Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:12 Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognition; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Galantamine; Indans; Learning; Male; Maze Learning; Mice; Mice, Inbred C57BL; Physostigmine; Piperidines; Receptors, Nicotinic	2005
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse (New York, N.Y.), 2007, Volume: 61, Issue:1 Topics: Acetylcholine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Fluorine Radioisotopes; Galantamine; Male; Physostigmine; Positron-Emission Tomography; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic	2007
Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex. Journal of Alzheimer's disease : JAD, 2009, Volume: 16, Issue:3 Topics: Acetylcholine; Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Galantamine; Humans; In Vitro Techniques; Indans; Middle Aged; Neocortex; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine; Young Adult	2009
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. Behavioural brain research, 2009, Oct-12, Volume: 203, Issue:1 Topics: Acetylcholine; Acetylcholinesterase; Air Pressure; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Galantamine; Hippocampus; Hypoxia; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Physostigmine; Random Allocation; Rats; Rats, Sprague-Dawley	2009
Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia. Experimental brain research, 2010, Volume: 203, Issue:3 Topics: Acetylcholine; Acetylcholinesterase; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Cerebral Cortex; Cholinesterase Inhibitors; Galantamine; Hypoxia; Learning Disabilities; Maze Learning; Nootropic Agents; Physostigmine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Space Perception	2010
Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats. Behavioural pharmacology, 2011, Volume: 22, Issue:1 Topics: Animals; Cholinesterase Inhibitors; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Galantamine; Generalization, Stimulus; Male; Nicotine; Nicotinic Agonists; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine	2011
Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats. The International journal of neuroscience, 2011, Volume: 121, Issue:5 Topics: Acetylcholine; Air Pressure; Altitude Sickness; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Hypoxia, Brain; Male; Maze Learning; Memory; Memory Disorders; Physostigmine; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome	2011
Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Jan-09, Volume: 33, Issue:2 Topics: Algorithms; Animals; Binding Sites; Cholinergic Agonists; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Galantamine; Hydrolysis; In Vitro Techniques; Ion Channels; Models, Molecular; Peptide Hydrolases; Photochemistry; Physostigmine; Polymerase Chain Reaction; Radioligand Assay; Receptors, GABA-A; Receptors, Nicotinic; Torpedo	2013
PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding. Synapse (New York, N.Y.), 2013, Volume: 67, Issue:12 Topics: Animals; Brain; Cholinesterase Inhibitors; Female; Galantamine; Physostigmine; Positron-Emission Tomography; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic	2013
Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test. Behavioural brain research, 2021, 07-09, Volume: 409 Topics: Animals; Antidepressive Agents; Association Learning; Behavior, Animal; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Repositioning; Galantamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Physostigmine; Rivastigmine; Swimming	2021